Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - haemagglutininum influenzae a (h1n1) (virus souche a/guangdong-maonan/swl1536/2019 (h1n1)-pdm09: reassortant virus cnic-19 derived from a/guangdong-maonan/swl1536/2019), haemagglutininum influenzae a (h3n2) (virus souche a/hong kong/2671/2019 (h3n2)-like: reassortant virus ivr-208 derived from a/hong kong/2671/2019), haemagglutininum influenzae b (virus souche b/washington/02/2019 (victoria lineage)) - sospensione iniettabile in siringa pre-riempita - haemagglutininum influenzae a (h1n1) (virus souche a/guangdong-maonan/swl1536/2019 (h1n1)-pdm09: reassortant virus cnic-19 derived from a/guangdong-maonan/swl1536/2019) 15 µg, haemagglutininum influenzae a (h3n2) (virus souche a/hong kong/2671/2019 (h3n2)-like: reassortant virus ivr-208 derived from a/hong kong/2671/2019) 15 µg, haemagglutininum influenzae b (virus souche b/washington/02/2019 (victoria lineage)) 15 µg, haemagglutininum influenzae b (virus souche b/phuket/3073/2013 (yamagata lineage)) 15 µg, natrii chloridum, kalii chloridum, dinatrii phosphas dihydricus, kalii dihydrogenophosphas, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.72 mg, kalium 0.08 mg, residui: formaldehydum, octoxinolum-9, neomycinum, ovalbuminum. - immunizzazione attiva contro l'influenza, come già nel 6 ° mese - vaccini

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

mylan pharma gmbh - haemagglutininum influenzae a (h1n1) (virus-stamm a/guangdong-maonan/swl1536/2019 (h1n1)-pdm09: reassortant virus cnic-1909 derived from a/guangdong-maonan/swl1536/2019), haemagglutininum influenzae a (h3n2) (virus-stamm a/hong kong/2671/2019 (h3n2)-like: reassortant virus ivr-208 derived from a/hong kong/2671/2019), haemagglutininum influenzae b (virus-stamm b/washington/02/2019 (victoria lineage)) - sospensione iniettabile - haemagglutininum influenzae a (h1n1) (virus-stamm a/guangdong-maonan/swl1536/2019 (h1n1)-pdm09: reassortant virus cnic-1909 derived from a/guangdong-maonan/swl1536/2019) 15 µg, haemagglutininum influenzae a (h3n2) (virus-stamm a/hong kong/2671/2019 (h3n2)-like: reassortant virus ivr-208 derived from a/hong kong/2671/2019) 15 µg, haemagglutininum influenzae b (virus-stamm b/washington/02/2019 (victoria lineage)) 15 µg, haemagglutininum influenzae b (virus-stamm b/phuket/3073/2013 (yamagata lineage)) 15 µg, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, natrii chloridum, calcii chloridum dihydricum, magnesii chloridum hexahydricum, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 2.0 mg, kalium 0.1 mg, residui: cetrimidum, formaldehydum, gentamicini sulfas, polysorbatum 80, ovalbuminum. - aktive immunisierung gegen influenza, ab 3 jahren - vaccini

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

glaxosmithkline ag - haemagglutininum influenzae a (h1n1) (virus stamm a/victoria/2570/2019 (h1n1)-like: reassortant virus ivr-215 derived from a/victoria/2570/2019), haemagglutininum influenzae a (h3n2) (virus stamm a/cambodia/e0826360/2020 (h3n2)-like: reassortant virus ivr-221 derived from a/tasmania/503/2020), haemagglutininum influenzae b (virus stamm b/washington/02/2019-like: reassortant virus b/washington/02/2019 (victoria lineage)) - sospensione iniettabile - haemagglutininum influenzae a (h1n1) (virus stamm a/victoria/2570/2019 (h1n1)-like: reassortant virus ivr-215 derived from a/victoria/2570/2019) 15 µg, haemagglutininum influenzae a (h3n2) (virus stamm a/cambodia/e0826360/2020 (h3n2)-like: reassortant virus ivr-221 derived from a/tasmania/503/2020) 15 µg, haemagglutininum influenzae b (virus stamm b/washington/02/2019-like: reassortant virus b/washington/02/2019 (victoria lineage)) 15 µg, haemagglutininum influenzae b (virus stamm b/phuket/3073/2013 (yamagata lineage)) 15 µg, polysorbatum 80, octoxinolum-10, natrii chloridum, magnesii chloridum hexahydricum, dinatrii phosphas dodecahydricus, kalii dihydrogenophosphas, kalii chloridum, alpha-tocopheroli hydrogenosuccinas, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml, residui: ovalbuminum, formaldehydum, natrii desoxycholas, gentamicini sulfas, hydrocortisonum. - immunizzazione attiva contro l'influenza, a partire da 36 mesi - vaccini

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - haemagglutininum influenzae a (h1n1) (virus souche a/victoria/2570/2019 (h1n1)-pdm09: reassortant virus ivr-215 derived from a/victoria/2570/2019), haemagglutininum influenzae a (h3n2) (virus souche a/cambodia/e0826360/2020 (h3n2)-like: reassortant virus ivr-221 derived from a/cambodia/e0826360/2020), haemagglutininum influenzae b (virus souche b/washington/02/2019 (victoria lineage)) - sospensione iniettabile in siringa pre-riempita - haemagglutininum influenzae a (h1n1) (virus souche a/victoria/2570/2019 (h1n1)-pdm09: reassortant virus ivr-215 derived from a/victoria/2570/2019) 15 µg, haemagglutininum influenzae a (h3n2) (virus souche a/cambodia/e0826360/2020 (h3n2)-like: reassortant virus ivr-221 derived from a/cambodia/e0826360/2020) 15 µg, haemagglutininum influenzae b (virus souche b/washington/02/2019 (victoria lineage)) 15 µg, haemagglutininum influenzae b (virus souche b/phuket/3073/2013 (yamagata lineage)) 15 µg, natrii chloridum, kalii chloridum, dinatrii phosphas dihydricus, kalii dihydrogenophosphas, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.72 mg, kalium 0.08 mg, residui: formaldehydum, octoxinolum-9, neomycinum, ovalbuminum. - immunizzazione attiva contro l'influenza, come già nel 6 ° mese - vaccini

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

mylan pharma gmbh - haemagglutininum influenzae a (h1n1) (virus-stamm a/victoria/2570/2019 (h1n1)-pdm09: reassortant virus ivr-215 derived from a/victoria/2570/2019), haemagglutininum influenzae a (h3n2) (virus-stamm a/cambodia/e0826360/2020 (h3n2)-like: reassortant virus ivr-224 derived from a/cambodia/e0826360/2020), haemagglutininum influenzae b (virus-stamm b/washington/02/2019 (victoria lineage)) - sospensione iniettabile - haemagglutininum influenzae a (h1n1) (virus-stamm a/victoria/2570/2019 (h1n1)-pdm09: reassortant virus ivr-215 derived from a/victoria/2570/2019) 15 µg, haemagglutininum influenzae a (h3n2) (virus-stamm a/cambodia/e0826360/2020 (h3n2)-like: reassortant virus ivr-224 derived from a/cambodia/e0826360/2020) 15 µg, haemagglutininum influenzae b (virus-stamm b/washington/02/2019 (victoria lineage)) 15 µg, haemagglutininum influenzae b (virus-stamm b/phuket/3073/2013 (yamagata lineage)) 15 µg, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, natrii chloridum, calcii chloridum dihydricum, magnesii chloridum hexahydricum, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 2.0 mg, kalium 0.1 mg, residui: cetrimidum, formaldehydum, gentamicini sulfas, polysorbatum 80, ovalbuminum. - aktive immunisierung gegen influenza, ab 6 monaten - vaccini

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

ebi-pharm ag - selenicereus grandiflorus d1, washington e produttività negli ultimi d1, kalii carbonas d3, nitroglycerinum d3, spigelia anthelmia d3 - omeopatici gocce - selenicereus grandiflorus d1 10 µl, washington e frutta fresca d1 964 µl, kalii carbonas d3 10 µl, nitroglycerinum d3 6 µl, spigelia anthelmia d3 10 µl di soluzione per 1 ml, corrisp. ethanolum 51 % v/v. - in caso di problemi di circolazione sanguigna delle coronarie - omeopatici

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

ebi-pharm ag - amanita muscaria (hab) d6, carbone vegetale (hab) d8, washington spag. peka tm, cytisus scoparius spag. peka d3, nicotiana tobago d6, veratrum album (hab) d4 - gocce per uso orale - amanita muscaria (hab) d6 150 mg, carbone vegetale (hab) d8 150 mg, washington spag. peka tm 250 mg, cytisus scoparius spag. peka d3 150 mg, nicotiana tobago d6 150 mg, veratrum album (hab) d4 150 mg di soluzione pro 1 g, corrisp. ethanolum 22 % v/v. - gemäss homöopathischem arzneimittelbild bei beschwerden bei niederem blutdruck - farmaci omeopatici

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

ebi-pharm ag - acido picrinicum (hab) d5, ammonium bromatum (hab) d1, avena sativa (hab) tm, matricaria recutita (hab) tm, washington (hab) tm, humulus lupulus (hab) tm, iperico perforato (hab) d1, potassio bromatum (hab) d1, melissa officinalis (hab) tm, sodio bromatum d1 (hab, 5a), valeriana officinalis (hab) tm - gocce per uso orale - acido picrinicum (hab) d5 0.1 g, ammonium bromatum (hab) d1 0.01 g, avena sativa (hab) tm 0,02 g, matricaria recutita (hab) tm 0,02 g, washington (hab) tm 0,05 g, humulus lupulus (hab) tm 0,05 g, iperico perforato (hab) d1 0,05 g, potassio bromatum (hab) d1 0.01 g, melissa officinalis (hab) tm 0,03 g, sodio bromatum d1 (hab, 5a) 0,01 g, valeriana officinalis (hab) tm 0.65 g, ethanolum il 96 per cento 0,55 g, acqua purificata, alla soluzione pro 1 g, corrisp. 22 gocce, corrisp. ethanolum 60 % v/v. - senza indicazione - farmaci omeopatici

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

regena ag - adonis vernalis (hab) d3, aesculus hippocastanum (hab) d3, arctium (hab) d4, arnica montana (hab) d8, colchicum autumnale (hab) d8, washington (hab) d2, kalmia latifolia (hab) d4, selenicereus grandiflorus (hab) d4, veratrum album (hab) d12 - gocce per uso orale - adonis vernalis (hab) d3 0,111 ml, aesculus hippocastanum (hab) d3 0,111 ml, arctium (hab) d4 0,111 ml, arnica montana (hab) d8 0,111 ml, colchicum autumnale (hab) d8 0,111 ml, washington (hab) d2 0,111 ml, kalmia latifolia (hab) d4 0,111 ml, selenicereus grandiflorus (hab) d4 0,111 ml, veratrum album (hab) d12 0,111 ml di acqua purificata, ethanolum il 96 per cento 0.39 g, per la soluzione 1 ml, corrisp. 46 gocce, corrisp. ethanolum 50 % v/v. - senza indicazione - farmaci omeopatici

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

spagyros ag - angelica archangelica, caffè arabica coltivato, washington, datura stramonium, valeriana officinalis, leonurus cardiaca melissa officinalis - spray per l'applicazione della cavità orale - 1 ml corrisp. dilutio spag. baumann d1 da angelica archangelica e caffè arabica coltivato e washington e la datura stramonium e valeriana officinalis e leonurus cardiaca e melissa officinalis e ana parti per la soluzione, corrisp. ethanolum 22-27 % v/v. - gemäss dem therapieprinzip der spagyrik unterstützend bei unruhezuständen und erregtheit, die sich in schlafproblemen, herzklopfen oder kopfschmerzen äussern - farmaci omeopatici